328 related articles for article (PubMed ID: 32361608)
1. In vitro and in vivo trans-epidermal water loss evaluation following topical drug delivery systems application for pharmaceutical analysis.
Cristiano MC; Froiio F; Mancuso A; Iannone M; Fresta M; Fiorito S; Celia C; Paolino D
J Pharm Biomed Anal; 2020 Jul; 186():113295. PubMed ID: 32361608
[TBL] [Abstract][Full Text] [Related]
2. Nanocarriers and their Actions to Improve Skin Permeability and Transdermal Drug Delivery.
Khan NR; Harun MS; Nawaz A; Harjoh N; Wong TW
Curr Pharm Des; 2015; 21(20):2848-66. PubMed ID: 25925113
[TBL] [Abstract][Full Text] [Related]
3. Vesicles: a recently developed novel carrier for enhanced topical drug delivery.
Akhtar N
Curr Drug Deliv; 2014; 11(1):87-97. PubMed ID: 24533724
[TBL] [Abstract][Full Text] [Related]
4. Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: A novel use as an anti-inflammatory agent in topical drug delivery.
Barone A; Cristiano MC; Cilurzo F; Locatelli M; Iannotta D; Di Marzio L; Celia C; Paolino D
Colloids Surf B Biointerfaces; 2020 Sep; 193():111152. PubMed ID: 32535351
[TBL] [Abstract][Full Text] [Related]
5. Ethosomes as Vesicles for Effective Transdermal Delivery: From Bench to Clinical Implementation.
Akhtar N; Varma A; Pathak K
Curr Clin Pharmacol; 2016; 11(3):168-190. PubMed ID: 27526697
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
Sala M; Diab R; Elaissari A; Fessi H
Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study.
Gupta PN; Mishra V; Rawat A; Dubey P; Mahor S; Jain S; Chatterji DP; Vyas SP
Int J Pharm; 2005 Apr; 293(1-2):73-82. PubMed ID: 15778046
[TBL] [Abstract][Full Text] [Related]
9. Transfersomes: self-optimizing carriers for bioactives.
Rai K; Gupta Y; Jain A; Jain SK
PDA J Pharm Sci Technol; 2008; 62(5):362-79. PubMed ID: 19055232
[TBL] [Abstract][Full Text] [Related]
10. Colloidal carriers for the enhanced delivery through the skin.
Cosco D; Celia C; Cilurzo F; Trapasso E; Paolino D
Expert Opin Drug Deliv; 2008 Jul; 5(7):737-55. PubMed ID: 18590459
[TBL] [Abstract][Full Text] [Related]
11. Liposomal formulation for dermal and transdermal drug delivery: past, present and future.
Nounou MI; El-Khordagui LK; Khalafallah NA; Khalil SA
Recent Pat Drug Deliv Formul; 2008; 2(1):9-18. PubMed ID: 19075893
[TBL] [Abstract][Full Text] [Related]
12. Vesicular carriers for dermal drug delivery.
Sinico C; Fadda AM
Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
[TBL] [Abstract][Full Text] [Related]
13. Ethosomes and Transfersomes: Principles, Perspectives and Practices.
Garg V; Singh H; Bimbrawh S; Singh SK; Gulati M; Vaidya Y; Kaur P
Curr Drug Deliv; 2017; 14(5):613-633. PubMed ID: 27199229
[TBL] [Abstract][Full Text] [Related]
14. Lipid vesicles: A versatile drug delivery platform for dermal and transdermal applications.
Chacko IA; Ghate VM; Dsouza L; Lewis SA
Colloids Surf B Biointerfaces; 2020 Nov; 195():111262. PubMed ID: 32736123
[TBL] [Abstract][Full Text] [Related]
15. Ability to estimate relative percutaneous penetration via a surrogate maker - trans epidermal water loss?
Hui X; Elkeeb R; Chan H; Maibach HI
Skin Res Technol; 2012 Feb; 18(1):108-13. PubMed ID: 21605169
[TBL] [Abstract][Full Text] [Related]
16. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
Zorec B; Zupančič Š; Kristl J; Pavšelj N
Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
[TBL] [Abstract][Full Text] [Related]
17. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
Shah DK; Khandavilli S; Panchagnula R
Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
[TBL] [Abstract][Full Text] [Related]
18. Liposomes and niosomes as topical drug delivery systems.
Choi MJ; Maibach HI
Skin Pharmacol Physiol; 2005; 18(5):209-19. PubMed ID: 16015019
[TBL] [Abstract][Full Text] [Related]
19. Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus.
Mbah CC; Builders PF; Attama AA
Expert Opin Drug Deliv; 2014 Jan; 11(1):45-59. PubMed ID: 24294974
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
